Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Balancing yield with tax efficiency in a bond ladder helps you capture higher after-tax income while managing interest-rate risk and withdrawals.
28,655 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Mastercard announces a new Virtual C-Suite to help small businesses run more efficiently. The AI suite starts with a ...
Developers shift from splashy amenities to intentional spaces that foster belonging, a move that also redefines how l...
A china tech fund opens a biotech position, signaling a broader shift toward life sciences within tech-driven portfol...
Big live events mix music with money. This guide breaks down how Ye’s Dutch concerts ahead can influence your budget,...
Two 2x MicroStrategy ETFs, MSTX and MSTU, are under renewed scrutiny as volatility tests the funds' synthetic exposur...
A fresh email alleging a secret phone may hold evidence in a missing-person case has sparked online chatter. This gui...
Palm Beach International Airport has been renamed Donald J. Trump International Airport, but the IATA code will remai...
Warner Bros. Discovery has formally labeled Paramount Skydance’s all-cash bid superior to Netflix’s, kicking off a sh...
When a mid-size fund dumps a sizable stake, it sends a signal about risk and opportunity. Kadensa Capital liquidates ...
SSR Mining's move to sell a large stake in a key asset sent its stock higher in a single session. This article breaks...
A sudden regulatory shift around tokenized stocks has sparked a wave of excitement and confusion. This Morning Minute...